Regdanvimab Antibody, Monoclonal | 21-958

Regdanvimab Antibody, Monoclonal | 21-958 | Gentaur UK, US & Europe Distribution

Product Type: Primary Antibodies

Category: Primary Antibodies, Monoclonal Antibodies

Research Area: Drug Analogues

Type: Monoclonal

Host Species: N/A

Reactivity Species: N/A

Homology: N/A

Immunology: Humanized / SARS-CoV-2 Spike RBD

Tested Application: N/A

Application Note: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Predicted Molecular Weight: N/A

Isoform: N/A

Purification: >95%

Clonality: Recombinant Monoclonal

Clone: N/A

Isotype: IgG1, Lambda

Conjugate: Unconjugated

Physical State: N/A

Buffer: PBS buffer pH 7.5

Concentration: N/A

Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks) . Store at -20 °C 12 months. Store at -80°C long term.

Additional Names: CT-P59, IMMUNOGLOBULIN G1, ANTI- (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL CT-P59 .GAMMA.-1 CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CT-P59 .LAMBDA.-CHAIN, DIMER REGDANVIMAB, REGDANVIMAB [INN], REGDANVIMAB [WHO-DD], spike glycoprotein

Protein Accession: P0DTC2

User Note: For research use only .

Background:

Loading Controls: N/A

Source: CHO cells

Purity: >95%

CAS: 2444308-95-4

Shipping Condition: N/A